Additionally, CAFs isolated from lung adenocarcinoma tissue produced CXCL12 in a conditioned medium, and CAF-derived CXCL12 enhanced EMT and cancer aggressiveness by upregulating the expression of CXCR4, β-catenin, and peroxisome proliferator-activated receptor δ 105. This evidence concerns the gene CXCL12 and cancer.